Newsroom
300 articles
Featured In a single year, FDA educational efforts prevented about 450,000 young people from beginning to use e-cigarettes According to a research co-authored by scientists from the U.S. Food…
Featured The Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the triple combination medication deutivacaftor/tezacaftor/vanzacaftor (brand name Alyftrek) to treat cystic fibrosis (CF) in individuals six years of…
Featured The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) are warning the public about the risks of unregulated advanced therapy medical products (ATMPs) available to…
Featured The Medicines and Healthcare Products Regulatory Agency (MHRA) has licensed mRNA respiratory syncytial virus (RSV) vaccine (brand name mRESVIA) to prevent individuals over the age of 60 from…
Featured The indication for post-operative pain management has been removed The indication for the management of post-operative pain has been removed from the licenses of all prolonged release opioids,…
Featured A new clinical trial map is now available on the Clinical Trials Information System (CTIS) public website. The map is intended to offer patients and healthcare professionals with…
Featured Adults with cerebrotendinous xanthomatosis (CTX) can now be treated with Ctexli (chenodiol), which is approved by the US Food and Drug Administration. Also, it’s The first FDA-approved medication…
Featured For the purpose of improving glycemic control in adults and pediatric patients with diabetes mellitus, the U.S. Food and Drug Administration authorized Merilog (insulin-aspart-szjj) as a biosimilar to…
Featured In order to provide vital safety alerts, the U.S. Food and Drug Administration is warning patients about a safety issue with diabetic devices that rely on smartphones, including…
Featured Nemolizumab, also known as Nemluvio, has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) to treat moderate to severe prurigo nodularis in adults aged 18…
Featured The Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the use of gozetotide (marketed under the name Illuccix) in a positioning emission tomography (PET) scan, a form…
Featured The MHRA has authorized the chikungunya vaccine (live) (brand name IXCHIQ) to prevent adults from chikungunya disease, which is caused by the chikungunya virus (CHIKV). CHIKV is spread…
Featured The Medicines and Healthcare Products Regulatory Agency (MHRA) has opened a consultation on regulatory guidance for personalized mRNA cancer immunotherapies (also known as cancer vaccines). This is a…
Featured The EMA’s human medicines committee (CHMP) has issued a good scientific opinion on Ivermectin/Albendazole for the treatment of illnesses caused by a variety of worm parasites, including lymphatic…
Featured The widespread use of azole fungicides (azoles), notably in some agricultural and horticultural operations, raises the possibility of Aspergillus fungus acquiring resistance to critical antifungal treatments. This noteworthy…
Talk to our experts and get tailored solutions to help you stay compliant and move forward with confidence.
Submit RFI/RFP
Request Consultation
Submit RFI/RFP